Serologic Response to Lower-Molecular-Weight Proteins of H. pylori Is Related to Clinical Outcome of H. pylori Infection in Taiwan

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Digestive Diseases and Sciences

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1005460130305PMID 10759250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody to a Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach.

  1998cited by this paper
• One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.

  1998cited by this paper
• Blood tests in the management of Helicobacter pylori infection

  1998cited by this paper
• Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia.

  1998cited by this paper
• Use of Immunoblot Assay To Define Serum Antibody Patterns Associated with Helicobacter pylori Infection and with H. pylori-Related Ulcers

  1998cited by this paper
• Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage.

  1998cited by this paper
• What are the host factors that place an individual at risk for Helicobacter pylori-associated disease?

  1997cited by this paper
• Helicobacter pylori factors associated with disease development.

  1997cited by this paper
• Clinical Application of Gastric Histology to Monitor Treatment of Dual Therapy in H. pylori Eradication

  1997influential reference
• High Seropositivity of Anti-CagA Antibody in Helicobacter pylori-Infected Patients Irrelevant to Peptic Ulcers and Normal Mucosa in Japan

  1997cited by this paper
• Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients.

  1997cited by this paper
• Uptake on Helicobacter pylori research. Pathogenesis and host response.

  1997cited by this paper
• CagA and the outcome of Helicobacter pylori infection.

  1996cited by this paper
• Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA

  1996cited by this paper
• The influence of size or number of biopsies on rapid urease test results: a prospective evaluation.

  1996cited by this paper
• Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention.

  1996cited by this paper
• Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.

  1996cited by this paper
• Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer.

  1996cited by this paper
• Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls.

  1996cited by this paper
• Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin

  1995cited by this paper
• Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

  1995cited by this paper
• The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer.

  1995cited by this paper
• Serologic detection of infection with cagA+ Helicobacter pylori strains

  1995cited by this paper
• Development of a mouse model of Helicobacter pylori infection that mimics human disease

  1995cited by this paper
• Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa.

  1994cited by this paper
• CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines.

  1994cited by this paper
• Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease.

  1994cited by this paper
• Possible role of Helicobacter pylori serology in reducing endoscopy workload.

  1994cited by this paper
• Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production

  1993cited by this paper
• Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

  1992cited by this paper
• Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity

  1990cited by this paper
• A sensitive and specific serologic test for detection of Campylobacter pylori infection.

  1989cited by this paper
• Campylobacter pylori and peptic ulcer disease.

  1989cited by this paper
• UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS

  1983cited by this paper
• Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

  1983cited by this paper

• Identification of serologically active Helicobacter pylori antigens related to alterations in serum pepsinogen levels.

  2023cites this paper
• cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease

  2011cites this paper
• Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.

  2009cites this paper
• Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.

  2009cites this paper
• Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.

  2007cites this paper
• Combined serumIgG response toHelicobacter pylori VacA and CagApredicts gastric cancer

  2007cites this paper
• Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay.

  2006cites this paper
• Quantitative Analysis of Representative Proteome Components and Clustering of Helicobacter pylori Clinical Strains

  2006cites this paper
• Research progress on Helicobacter pylori outer membrane protein.

  2005influential citation
• Serological Responses of FldA and Small‐Molecular‐Weight Proteins of Helicobacter pylori: Correlation with the Presence of the Gastric MALT Tissue

  2004cites this paper
• Cloning and sequence analysis of gene oipA encoding an outer membrane protein of human Helicobacter pylori.

  2004cites this paper
• Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins.

  2004cites this paper
• Clinical and pathological implications of IgG antibody responses toHelicobacter pyloriand its virulence factors in non‐ulcer dyspepsia

  2003cites this paper
• Clinical Application of 20 MHz Endosonography and Anti‐Helicobacter pylori Immunoblots to Predict Regression of Low‐grade Gastric MALToma by H. pylori Eradication

  2003cites this paper
• cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi'an area.

  2003cites this paper
• Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

  2003cites this paper
• Crystal structure of oxidized flavodoxin, an essential protein in Helicobacter pylori

  2002cites this paper
• Helicobacter pylori-Specific Immune Responses of Children: Implications for Future Vaccination Strategy

  2002cites this paper
• Specific identification of three low molecular weight membrane‐associated antigens of Helicobacter pylori

  2002cites this paper
• Seroreactivity to 19.5‐kDa Antigen in Combination with Absence of Seroreactivity to 35‐kDa Antigen is Associated with an Increased Risk of Gastric Adenocarcinoma

  2002cites this paper
• A study of recombinant protective H.pylori antigens.

  2002cites this paper
• Vaccine against Helicobacter pylori?

  2001cites this paper
• Overexpression and purification of Helicobacter pylori flavodoxin and induction of a specific antiserum in rabbits.

  2001cites this paper
• Nonspecific but prognostic Helicobacter pylori and gastric cancer association.

  2000cites this paper